Sunshine Biopharma Inc (SBFM)

[SmokeSignals]

take profits: The patents will cost a whopping $12.9 million and this amount should be paid in quarterly installments before the end of 2020. Unfortunately, the latest 10-Q suggest that the company might have some problems keeping up with the payment schedule. Here's what the balance sheet looked like on September 30:

cash: $125 thousand
total assets: $137 thousand
current liabilities: $470 thousand
NO revenue
quarterly net loss: $203 thousand
The figures aren't the only worrying thing about the 10-Q. There's also some convertible debt and as you can see from the chart at the beginning of the article, it is already putting pressure on the stock.

During the first nine months of 2015, the company issued just over 39 million shares at an average rate of $0.0084 in order to satisfy about $343 thousand worth of notes, and during the same period, it picked up a further $245 thousand worth of debt convertible at a 35% discount. On October 28, $12 thousand worth of notes was converted into more than 3.1 million shares which pushed the conversion rate even lower - $0.0037 per share.